Remiges raises $70 million for $150 million fund

Remiges Ventures has raised $70 million of the targeted $150 million in its Remiges BioPharma Fund L.P., according to an SEC filing. The firm will invest in early stage companies in the U.S. and Europe that are developing therapeutics "with a definable commercial opportunity in the U.S. market." Taiho Pharmaceutical Co. Ltd. (Tokyo, Japan) and Sumitomo Dainippon Pharma Co. Ltd. (Tokyo:4506) are each investing $30 million in the fund. Remiges, which could not be reached for comment, has offices in Cambridge, Mass., and Tokyo. ...